Literature DB >> 15871685

The nonviral episomal replicating vector pEPI-1 allows long-term inhibition of bcr-abl expression by shRNA.

Andreas C W Jenke1, Tobias Eisenberger, Armin Baiker, Isa M Stehle, Stefan Wirth, Hans Joachim Lipps.   

Abstract

The inhibition of gene expression by RNA interference harbors a high potential for application in the therapy of human diseases. However, while exogenous application of siRNAs efficiently inhibits gene expression, these effects are only transient in mammalian cells. We designed a short hairpin RNA-expression cassette to target the bcr-abl oncogene that was then introduced into the nonviral vector system pEPI-1, which replicates episomally in the absence of selection in the bcr-abl-positive cell line K562. Forty-two days after transfection the bcr-abl- but not the cytokine-dependent growth rate was found to be drastically reduced in K562 cells. Western analysis revealed a more than 90% reduction in the expression of the fusion protein bcr-abl while the expression of the bcr protein remained unaffected. In addition, we show that the level of bcr-abl mRNA was specifically reduced in these cells for more than 90%. These results demonstrate that the vector system pEPI-1 allows specific and efficient long term gene suppression by using a short hairpin RNA transcription unit.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15871685     DOI: 10.1089/hum.2005.16.533

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  10 in total

1.  Identification of new human origins of DNA replication by an origin-trapping assay.

Authors:  Jeannine Gerhardt; Samira Jafar; Mark-Peter Spindler; Elisabeth Ott; Aloys Schepers
Journal:  Mol Cell Biol       Date:  2006-09-05       Impact factor: 4.272

Review 2.  Nanoparticle-based technologies for retinal gene therapy.

Authors:  Jeffrey Adijanto; Muna I Naash
Journal:  Eur J Pharm Biopharm       Date:  2015-01-12       Impact factor: 5.571

3.  pEPito: a significantly improved non-viral episomal expression vector for mammalian cells.

Authors:  Rudolf Haase; Orestis Argyros; Suet-Ping Wong; Richard P Harbottle; Hans J Lipps; Manfred Ogris; Terese Magnusson; Maria G Vizoso Pinto; Jürgen Haas; Armin Baiker
Journal:  BMC Biotechnol       Date:  2010-03-15       Impact factor: 2.563

4.  S/MAR-containing DNA nanoparticles promote persistent RPE gene expression and improvement in RPE65-associated LCA.

Authors:  Adarsha Koirala; Rasha S Makkia; Shannon M Conley; Mark J Cooper; Muna I Naash
Journal:  Hum Mol Genet       Date:  2013-01-18       Impact factor: 6.150

5.  Long-term suppression of hepatitis B virus replication by short hairpin RNA expression using the scaffold/matrix attachment region-based replicating vector system pEPI-1.

Authors:  Andreas C W Jenke; Andreas D Wilhelm; Valerie Orth; Hans Joachim Lipps; Ulrike Protzer; Stefan Wirth
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

6.  Generation of a tumor- and tissue-specific episomal non-viral vector system.

Authors:  Rudolf Haase; Terese Magnusson; Baowei Su; Florian Kopp; Ernst Wagner; Hans Lipps; Armin Baiker; Manfred Ogris
Journal:  BMC Biotechnol       Date:  2013-06-04       Impact factor: 2.563

7.  Genetic modification of dividing cells using episomally maintained S/MAR DNA vectors.

Authors:  Suet-Ping Wong; Richard Paul Harbottle
Journal:  Mol Ther Nucleic Acids       Date:  2013-08-13       Impact factor: 10.183

8.  CD74 interferes with the expression of fas receptor on the surface of lymphoma cells.

Authors:  Zuzana Berkova; Shu Wang; Xue Ao; Jillian F Wise; Frank K Braun; Abdol H Rezaeian; Lalit Sehgal; David M Goldenberg; Felipe Samaniego
Journal:  J Exp Clin Cancer Res       Date:  2014-10-10

9.  Impact of Different Promoters on Episomal Vectors Harbouring Characteristic Motifs of Matrix Attachment Regions.

Authors:  Xiao-Yin Wang; Jun-He Zhang; Xi Zhang; Qiu-Li Sun; Chun-Peng Zhao; Tian-Yun Wang
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

10.  Advances in the Development and the Applications of Nonviral, Episomal Vectors for Gene Therapy.

Authors:  Grace Elizabeth Mulia; Virginia Picanço-Castro; Eleana F Stavrou; Aglaia Athanassiadou; Marxa Leão Figueiredo
Journal:  Hum Gene Ther       Date:  2021-09-20       Impact factor: 5.695

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.